Terminology Service for NFDI4Health
All terms in MESH
| Label | Id | Description |
|---|---|---|
| Antigens, Tumor-Associated, Carbohydrate | D015295 | [Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies.] |
| NADPH-dependent L-sorbose dehydrogenase | C446052 | |
| Fura-2 | D016257 | [A fluorescent calcium chelating agent which is used to study intracellular calcium in tissues.] |
| Oxazoles | D010080 | [Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions.] |
| 5-valproylamido-1,3,4-thiadiazole-2-sulfonamide | C446053 | |
| Genes, mos | D016258 | [Retrovirus-associated DNA sequences (mos) originally isolated from the Moloney murine sarcoma virus (Mo-MSV). The proto-oncogene mos (c-mos) codes for a protein which is a member of the serine kinase family. There is no evidence as yet that human c-mos can become transformed or has a role in human cancer. However, in mice, activation can occur when the retrovirus-like intracisternal A-particle inserts itself near the c-mos sequence. The human c-mos gene is located at 8q22 on the long arm of chromosome 8.] |
| 3-(undec-10-enoylamino)glutarimide | C446054 | |
| Genes, myc | D016259 | [Family of retrovirus-associated DNA sequences (myc) originally isolated from an avian myelocytomatosis virus. The proto-oncogene myc (c-myc) codes for a nuclear protein which is involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Truncation of the first exon, which appears to regulate c-myc expression, is crucial for tumorigenicity. The human c-myc gene is located at 8q24 on the long arm of chromosome 8.] |
| 7-(4'-(N-alpha-methylbenzylaminoacylaminophenyl)thio)pregna-4-ene-3,20-dione | C446055 | |
| 2-methyl-8-quinolyl 8-chloro-5,5-dioxoimidazo(1,2-b)(1,4,2)benzodithiazine-7-carboxylate | C446056 | |
| National Institute of Neurological Disorders and Stroke (U.S.) | D055825 | [Component of the NATIONAL INSTITUTES OF HEALTH. It supports and conducts research, both basic and clinical, on the normal and diseases nervous system. It was established in 1950.] |
| National Institutes of Health (U.S.) | D009316 | [An operating division of the US Department of Health and Human Services. It is concerned with the overall planning, promoting, and administering of programs pertaining to health and medical research.] |
| Afghan Campaign 2001- | D055826 | [Multinational coalition military operation initiated in October 2001 to counter terrorism and bring security to AFGHANISTAN in collaboration with Afghan forces.] |
| Armed Conflicts | D000068337 | [Any differences arising between two nations or groups and leading to the intervention of armed forces.] |
| History, 21st Century | D049674 | [Events and developments in medicine during the 100 year period following the 20th century., Events of lasting impact or importance occurring in the 21st century., Time period from 2001 through 2100 of the common era.] |
| Integumentary System Physiological Phenomena | D055827 | [The properties and relationships and biological processes that characterize the nature and function of the SKIN and its appendages.] |
| DIAM 4 | C050390 | |
| DNA modification methylase DdeI | C050391 | |
| chromatin 3'-phosphatase-5'-hydroxy kinase | C050392 | |
| 2'-deoxynebularine | C050393 |